Virtual biopsy for non-invasive identification of follicular lymphoma histologic transformation using radiomics-based imaging biomarker from PET/CT

Abstract Background This study aimed to construct a radiomics-based imaging biomarker for the non-invasive identification of transformed follicular lymphoma (t-FL) using PET/CT images. Methods A total of 784 follicular lymphoma (FL), diffuse large B-cell lymphoma, and t-FL patients from 5 independen...

Full description

Saved in:
Bibliographic Details
Main Authors: Chong Jiang, Chunjun Qian, Qiuhui Jiang, Hang Zhou, Zekun Jiang, Yue Teng, Bing Xu, Xin Li, Chongyang Ding, Rong Tian
Format: Article
Language:English
Published: BMC 2025-01-01
Series:BMC Medicine
Subjects:
Online Access:https://doi.org/10.1186/s12916-025-03893-7
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832571601001906176
author Chong Jiang
Chunjun Qian
Qiuhui Jiang
Hang Zhou
Zekun Jiang
Yue Teng
Bing Xu
Xin Li
Chongyang Ding
Rong Tian
author_facet Chong Jiang
Chunjun Qian
Qiuhui Jiang
Hang Zhou
Zekun Jiang
Yue Teng
Bing Xu
Xin Li
Chongyang Ding
Rong Tian
author_sort Chong Jiang
collection DOAJ
description Abstract Background This study aimed to construct a radiomics-based imaging biomarker for the non-invasive identification of transformed follicular lymphoma (t-FL) using PET/CT images. Methods A total of 784 follicular lymphoma (FL), diffuse large B-cell lymphoma, and t-FL patients from 5 independent medical centers were included. The unsupervised EMFusion method was applied to fuse PET and CT images. Deep-based radiomic features were extracted from the fusion images using a deep learning model (ResNet18). These features, along with handcrafted radiomics, were utilized to construct a radiomic signature (R-signature) using automatic machine learning in the training and internal validation cohort. The R-signature was then tested for its predictive ability in the t-FL test cohort. Subsequently, this R-signature was combined with clinical parameters and SUVmax to develop a t-FL scoring system. Results The R-signature demonstrated high accuracy, with mean AUC values as 0.994 in the training cohort and 0.976 in the internal validation cohort. In the t-FL test cohort, the R-signature achieved an AUC of 0.749, with an accuracy of 75.2%, sensitivity of 68.0%, and specificity of 77.5%. Furthermore, the t-FL scoring system, incorporating the R-signature along with clinical parameters (age, LDH, and ECOG PS) and SUVmax, achieved an AUC of 0.820, facilitating the stratification of patients into low, medium, and high transformation risk groups. Conclusions This study offers a promising approach for identifying t-FL non-invasively by radiomics analysis on PET/CT images. The developed t-FL scoring system provides a valuable tool for clinical decision-making, potentially improving patient management and outcomes.
format Article
id doaj-art-93b444a7b4224174b6f61580e1c3e2a3
institution Kabale University
issn 1741-7015
language English
publishDate 2025-01-01
publisher BMC
record_format Article
series BMC Medicine
spelling doaj-art-93b444a7b4224174b6f61580e1c3e2a32025-02-02T12:28:09ZengBMCBMC Medicine1741-70152025-01-0123111410.1186/s12916-025-03893-7Virtual biopsy for non-invasive identification of follicular lymphoma histologic transformation using radiomics-based imaging biomarker from PET/CTChong Jiang0Chunjun Qian1Qiuhui Jiang2Hang Zhou3Zekun Jiang4Yue Teng5Bing Xu6Xin Li7Chongyang Ding8Rong Tian9Department of Nuclear Medicine, West China Hospital, Sichuan University, Guoxue AlleySchool of Electrical and Information Engineering, Changzhou Institute of TechnologyDepartment of Hematology, School of Medicine, The First Affiliated Hospital of Xiamen University and Institute of Hematology, Xiamen UniversityDepartment of Nuclear Medicine, Qilu Hospital of Shandong UniversityBiomedical Big Data Center, West China Hospital, Sichuan UniversityDepartment of Nuclear Medicine, Nanjing Drum Tower Hospital, the Affiliated Hospital of Nanjing University Medical SchoolDepartment of Hematology, School of Medicine, The First Affiliated Hospital of Xiamen University and Institute of Hematology, Xiamen UniversityDepartment of Nuclear Medicine, Qilu Hospital of Shandong UniversityDepartment of Nuclear Medicine, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province HospitalDepartment of Nuclear Medicine, West China Hospital, Sichuan University, Guoxue AlleyAbstract Background This study aimed to construct a radiomics-based imaging biomarker for the non-invasive identification of transformed follicular lymphoma (t-FL) using PET/CT images. Methods A total of 784 follicular lymphoma (FL), diffuse large B-cell lymphoma, and t-FL patients from 5 independent medical centers were included. The unsupervised EMFusion method was applied to fuse PET and CT images. Deep-based radiomic features were extracted from the fusion images using a deep learning model (ResNet18). These features, along with handcrafted radiomics, were utilized to construct a radiomic signature (R-signature) using automatic machine learning in the training and internal validation cohort. The R-signature was then tested for its predictive ability in the t-FL test cohort. Subsequently, this R-signature was combined with clinical parameters and SUVmax to develop a t-FL scoring system. Results The R-signature demonstrated high accuracy, with mean AUC values as 0.994 in the training cohort and 0.976 in the internal validation cohort. In the t-FL test cohort, the R-signature achieved an AUC of 0.749, with an accuracy of 75.2%, sensitivity of 68.0%, and specificity of 77.5%. Furthermore, the t-FL scoring system, incorporating the R-signature along with clinical parameters (age, LDH, and ECOG PS) and SUVmax, achieved an AUC of 0.820, facilitating the stratification of patients into low, medium, and high transformation risk groups. Conclusions This study offers a promising approach for identifying t-FL non-invasively by radiomics analysis on PET/CT images. The developed t-FL scoring system provides a valuable tool for clinical decision-making, potentially improving patient management and outcomes.https://doi.org/10.1186/s12916-025-03893-7Follicular lymphomaHistologic transformationScoring systemRadiomicsPET/CT
spellingShingle Chong Jiang
Chunjun Qian
Qiuhui Jiang
Hang Zhou
Zekun Jiang
Yue Teng
Bing Xu
Xin Li
Chongyang Ding
Rong Tian
Virtual biopsy for non-invasive identification of follicular lymphoma histologic transformation using radiomics-based imaging biomarker from PET/CT
BMC Medicine
Follicular lymphoma
Histologic transformation
Scoring system
Radiomics
PET/CT
title Virtual biopsy for non-invasive identification of follicular lymphoma histologic transformation using radiomics-based imaging biomarker from PET/CT
title_full Virtual biopsy for non-invasive identification of follicular lymphoma histologic transformation using radiomics-based imaging biomarker from PET/CT
title_fullStr Virtual biopsy for non-invasive identification of follicular lymphoma histologic transformation using radiomics-based imaging biomarker from PET/CT
title_full_unstemmed Virtual biopsy for non-invasive identification of follicular lymphoma histologic transformation using radiomics-based imaging biomarker from PET/CT
title_short Virtual biopsy for non-invasive identification of follicular lymphoma histologic transformation using radiomics-based imaging biomarker from PET/CT
title_sort virtual biopsy for non invasive identification of follicular lymphoma histologic transformation using radiomics based imaging biomarker from pet ct
topic Follicular lymphoma
Histologic transformation
Scoring system
Radiomics
PET/CT
url https://doi.org/10.1186/s12916-025-03893-7
work_keys_str_mv AT chongjiang virtualbiopsyfornoninvasiveidentificationoffollicularlymphomahistologictransformationusingradiomicsbasedimagingbiomarkerfrompetct
AT chunjunqian virtualbiopsyfornoninvasiveidentificationoffollicularlymphomahistologictransformationusingradiomicsbasedimagingbiomarkerfrompetct
AT qiuhuijiang virtualbiopsyfornoninvasiveidentificationoffollicularlymphomahistologictransformationusingradiomicsbasedimagingbiomarkerfrompetct
AT hangzhou virtualbiopsyfornoninvasiveidentificationoffollicularlymphomahistologictransformationusingradiomicsbasedimagingbiomarkerfrompetct
AT zekunjiang virtualbiopsyfornoninvasiveidentificationoffollicularlymphomahistologictransformationusingradiomicsbasedimagingbiomarkerfrompetct
AT yueteng virtualbiopsyfornoninvasiveidentificationoffollicularlymphomahistologictransformationusingradiomicsbasedimagingbiomarkerfrompetct
AT bingxu virtualbiopsyfornoninvasiveidentificationoffollicularlymphomahistologictransformationusingradiomicsbasedimagingbiomarkerfrompetct
AT xinli virtualbiopsyfornoninvasiveidentificationoffollicularlymphomahistologictransformationusingradiomicsbasedimagingbiomarkerfrompetct
AT chongyangding virtualbiopsyfornoninvasiveidentificationoffollicularlymphomahistologictransformationusingradiomicsbasedimagingbiomarkerfrompetct
AT rongtian virtualbiopsyfornoninvasiveidentificationoffollicularlymphomahistologictransformationusingradiomicsbasedimagingbiomarkerfrompetct